ADR Stock Overview
Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 6/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Adherium Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.014 |
| 52 Week High | AU$0.093 |
| 52 Week Low | AU$0.011 |
| Beta | 2.65 |
| 11 Month Change | 0% |
| 3 Month Change | -17.65% |
| 1 Year Change | -76.67% |
| 33 Year Change | -92.82% |
| 5 Year Change | -98.30% |
| Change since IPO | -99.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| ADR | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 0% | 3.1% | 0.6% |
| 1Y | -76.7% | 126.8% | 19.9% |
Return vs Industry: ADR underperformed the Australian Healthcare Services industry which returned 126.8% over the past year.
Return vs Market: ADR underperformed the Australian Market which returned 19.9% over the past year.
Price Volatility
| ADR volatility | |
|---|---|
| ADR Average Weekly Movement | 17.6% |
| Healthcare Services Industry Average Movement | 7.9% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.6% |
Stable Share Price: ADR's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: ADR's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Paul Mastoridis | www.adherium.com |
Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around patient inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal, as well as Hailie remote patient management solution.
Adherium Limited Fundamentals Summary
| ADR fundamental statistics | |
|---|---|
| Market cap | AU$10.48m |
| Earnings (TTM) | -AU$10.22m |
| Revenue (TTM) | AU$840.98k |
12.5x
P/S Ratio-1.0x
P/E RatioIs ADR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ADR income statement (TTM) | |
|---|---|
| Revenue | AU$840.98k |
| Cost of Revenue | AU$573.28k |
| Gross Profit | AU$267.70k |
| Other Expenses | AU$10.49m |
| Earnings | -AU$10.22m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.014 |
| Gross Margin | 31.83% |
| Net Profit Margin | -1,215.74% |
| Debt/Equity Ratio | 0% |
How did ADR perform over the long term?
See historical performance and comparison